Pairing the antidepressant amitriptyline with drugs designed to treat central nervous system diseases, enhances drug delivery to the brain by inhibiting the blood-brain barrier in rats, new research shows. The blood-brain barrier serves as a natural, protective boundary, preventing most drugs from entering the brain.